Pregnancy Clinical Trial
Official title:
Smoking Cessation for Low-Income Pregnant Women
To meet the Healthy People 2010 objective of increasing tobacco abstinence among pregnant
women to 90%, new methods for treating nicotine addiction among pregnant women are needed.
To this end, we propose to evaluate an innovative cognitive-behavioral smoking cessation
intervention for low-income, minority women conducted in the prenatal and postpartum phases.
Considering the strong link between tobacco use and cancer risk, the development of
effective smoking cessation treatments has important health implications for cancer
prevention and control initiatives. The aims to be addressed are:
Aim 1: To compare an enhanced Cognitive-Behavioral Counseling (CBC) smoking cessation
intervention with a Best Practice control condition (BP) for reducing smoking rates (i.e.,
continued abstinence, 7-day point prevalence, and number of cigarettes smoked) in the short-
and long-term among pregnant women. It is hypothesized that smokers receiving CBC will show
reduced rates of tobacco use, versus those in the BP, over time.
Aim 2: To evaluate the impact of the CBC intervention on the hypothesized mediators of
behavior change (i.e., heightened risk perceptions; enhanced self-efficacy and reduced
fatalistic beliefs; high pros and low cons of quitting; reduced emotional distress). It is
hypothesized that the psychosocial factors will mediate the effect of the CBC intervention
on change of smoking behaviors.
Rates of Smoking Among Pregnant and Postpartum Women.
Despite the well-established health risks of prenatal and postpartum smoking, a sizable
number of pregnant women and new mothers smoke. About 30% of US women who become pregnant
smoke. Only 20-40% of these women spontaneously quit upon learning of their pregnancy.
Although an additional 3-16% of pregnant smokers may quit later in pregnancy, the majority
continue to smoke throughout, with 15-30% relapsing. Research has also indicated that
smoking cessation rates are lower among low-income pregnant women (6-14%) versus more
affluent populations. Less educated, lower SES, unemployed women who have a higher addiction
to nicotine are at greatest risk for smoking throughout their pregnancy, while pregnant
women with higher levels of education and income are more likely to quit. These differential
smoking rates result in elevated rates of high-risk pregnancies for low SES and less
educated women, vs. higher SES and educated women. While some research has demonstrated
moderate success with prenatal smoking cessation interventions, relapse remains a prominent
concern. Indeed, more than a quarter of women who quit spontaneously relapse by 6-weeks
postpartum, with relapse rates reported as high as 60-80% by 6-months postpartum. The
highest relapse rates have been found among women with low income and little education.
Smoking Cessation Interventions for Prenatal and Postpartum Women.
To date, the efficacy of available smoking cessation interventions has been disappointing.
The current literature on tobacco control indicates that cognitive-affective factors
(including perceived risk, self-efficacy, fatalism, decisional balance, and affect) need to
be considered when designing smoking cessation protocols. Yet, the behavioral treatments
that have been tested for pregnant smokers focus on the use of self-help guides, basic
skills training, and education, neglecting the individual's cognitive-affective profile of
barriers. This limitation is paralleled by a similar void in the broader smoking cessation
literature. When these characteristics are addressed, they have been considered in
isolation, without attention to the full spectrum of cognitive-affective barriers to
quitting (i.e., the interventions focus on only 1 barrier such as perceived risk or
depression). Not surprisingly, among intervention studies with pregnant women, only 3
produced quit rates above 20%.
Thus, research now needs to build upon these guidelines to develop more potent smoking
cessation interventions. The design of our intervention is directly responsive to the call
for the development of more creative and powerful behavioral interventions to replace the
current best available programs. Guided by the Cognitive-Social Health Information
Processing (C-SHIP) model and based on our related behavior change protocols for low-income
populations, our approach is tailored to the woman's cognitive-affective profile of barriers
to initial, and sustained, uptake of smoking cessation.
Determinants of Smoking Cessation Among Pregnant Women.
The exploration of psychological factors as potential mediators of behavior change appears
to be particularly promising. The specific cognitive and affective processes proposed by the
C-SHIP model as determinants of the uptake of individual health-protective behaviors (e.g.,
smoking cessation) include: 1) perceived risk; 2) self-efficacy and fatalistic beliefs; 3)
expectancies of consequences (i.e., the pros and cons of cessation); and 4) emotional
distress. Over the past decade, a sizable literature has accumulated with respect to the
psychological correlates of smoking behavior.
Procedures and Interventions
Women who were between 1-25 weeks gestation were asked to participate in a study aimed at
learning about smoking cessation techniques for quitting and relapse prevention. Following
recruitment and informed consent, participants were randomly assigned to one of two groups,
which varied in intensity: 1) the control group, which provided a brief counseling of
educational advice and assistance for quitting during each session or 2) a more intensive
theoretically-guided smoking cessation intervention group based on the team's
Cognitive-Social Health Information Processing Model (C-SHIP ), which assessed and addressed
the participant's distinctive pattern of risk perceptions, expectancies and beliefs, and
affective reactions. Through prompts and role-play exercises in the context of in-person
counseling, potential barriers to cessation can be triggered in a safe, supportive
environment. Baseline and follow-up assessments were conducted at 13-25 weeks gestation,
26-38 weeks gestation, 2-6 weeks postpartum and 20-22 weeks postpartum.
Best Practice (BP) control condition consisted of two on-site 10-15 minutes sessions
(session 1 and 3), pick up a smoking cessation guide/brochure (session 2), and receive an
educational new letter by mail (booster session). CBC intervention included two 45 minutes
on-site counseling sessions session 1 and 3), one 15-minutes on-site counseling session
(session 2), and one 15-minutes phone session (booster session).
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
Completed |
NCT03218956 -
Protein Requirement During Lactation
|
N/A | |
Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
Terminated |
NCT02537145 -
PregnanT Moms Measure - Do-It-Yourself Health Monitoring and Simulation of Health in Pregnant Women
|